Stay updated on Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page
- CheckyesterdayChange DetectedOnly minor UI/layout adjustments to headers and page structure are evident, with no substantive changes to study details (title, purpose, endpoints, eligibility criteria, enrollment, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

 - Check9 days agoNo Change Detected
 - Check30 days agoChange DetectedAdded a government funding notice and an updated software version (v3.2.0), removing the old v3.1.0; this primarily updates the page’s operating status guidance and versioning.SummaryDifference3%

 - Check37 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

 - Check52 days agoChange DetectedThe page revision was bumped from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.2%

 - Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

 - Check66 days agoChange DetectedThe web page has updated its facility name and location details, adding several new locations while removing previous ones. Additionally, there is a new version revision noted.SummaryDifference4%

 
Stay in the know with updates to Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.